SCHMERTZLER MICHAEL Insider Trading Activity

Average Profitability
49.41%
Insider Buys Quantity
6
Insider Buys Sum
$17.21M
Insider Sells Quantity
10
Insider Sells Sum
$6.41M

Insider Activity of SCHMERTZLER MICHAEL

According to the SEC Form 4 filings, SCHMERTZLER MICHAEL, being in a position of

  1. director at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 95000 shares for $6.62M,
    over all time since 2013-03-07, has bought 911841 share for $11.21M, and sold 97500 shares for $6.71M.

Biography of SCHMERTZLER MICHAEL

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $6,620,96910100

Comparison of Insiders on Amount of Buys and Sells

2026-10-14SalePTC Therapeutics, Inc.
PTCT
director
2,500
0.003%
$59.61$149,037+3.59%
2026-10-07SalePTC Therapeutics, Inc.
PTCT
director
2,500
0.003%
$63.39$158,480-1.8%
2026-09-17SalePTC Therapeutics, Inc.
PTCT
director
10,000
0.012%
$67.85$678,533-7.47%
2026-09-16SalePTC Therapeutics, Inc.
PTCT
director
10,000
0.0119%
$67.12$671,195-6.84%
2026-09-10SalePTC Therapeutics, Inc.
PTCT
director
10,000
0.012%
$67.34$673,400-6.29%
2026-09-09SalePTC Therapeutics, Inc.
PTCT
director
10,000
0.012%
$67.84$678,403-6.42%
2026-08-27SalePTC Therapeutics, Inc.
PTCT
director
12,500
0.0149%
$71.58$894,784-10.69%
2026-08-26SalePTC Therapeutics, Inc.
PTCT
director
12,500
0.015%
$72.94$911,725-11.55%
2026-08-20SalePTC Therapeutics, Inc.
PTCT
director
12,500
0.0151%
$71.11$888,858-8.2%
2026-08-19SalePTC Therapeutics, Inc.
PTCT
director
12,500
0.0149%
$73.32$916,554-12.07%
2024-01-08SalePTC Therapeutics, Inc.
PTCT
director
1,500
0.0019%
$27.81$41,715+11.97%
2023-06-07SalePTC Therapeutics, Inc.
PTCT
director
1,000
0.0014%
$44.86$44,860-34.53%
2020-03-16PurchasePTC Therapeutics, Inc.
PTCT
director
20,000
0.0322%
$32.48$649,692+60.5%
2019-01-25PurchasePTC Therapeutics, Inc.
PTCT
director
66,225
0.1217%
$30.20$2M+38.99%
2014-02-19PurchasePTC Therapeutics, Inc.
PTCT
23,000
0.0806%
$24.50$563,500+12.68%
2013-06-25PurchasePTC Therapeutics, Inc.
PTCT
533,333
1.9161%
$15.00$8M+8.52%
2013-03-07PurchasePTC Therapeutics, Inc.
PTCT
269,283
–
$0$0
2010-06-03SaleCytokinetics, Incorporated
CYTK
director
10,764
0.0169%
$3.00$32,292-27.76%
2010-05-27SaleCytokinetics, Incorporated
CYTK
director
115,216
0.1805%
$3.00$345,648-27.33%
2010-05-19SaleCytokinetics, Incorporated
CYTK
director
32,478
0.0516%
$3.00$97,434-25.34%
Total: 26
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.